Solutions We Offer

Chemistry solutions and process R&D

Contact Us
Solutions We Offer

Innovative Chemistry

Explore state-of-the-art lab technologies

Contact Us
Innovative Chemistry
about-img

About SynZeal

SynZeal Research is an independent research driven company specialized in the custom synthesis of pharmacopeial & non-pharmacopeial reference standards, drug glucuronides, drug metabolites, Isotope labelled reference standards and focused compound libraries. As a research-driven organization, we have developed novel processes to make niche products required to pharmaceutical companies globally at various platform. We understand the industry research needs thoroughly and have earned reputation for being most reliable innovator of pharmaceutical reference standards worldwide.

LATEST EVENTS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec pretium scelerisque enim a ullamcorper. Curabitur ullamcorper pulvinar elit volutpat pharetra. Sed molestie ex vitae elit dignissim egestas. Morbi ultricies quam urna, eu cursus ante dignissim in.

UPCOMING EVENTS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec pretium scelerisque enim a ullamcorper. Curabitur ullamcorper pulvinar elit volutpat pharetra. Sed molestie ex vitae elit dignissim egestas. Morbi ultricies quam urna, eu cursus ante dignissim in.

PAST EVENTS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec pretium scelerisque enim a ullamcorper. Curabitur ullamcorper pulvinar elit volutpat pharetra. Sed molestie ex vitae elit dignissim egestas. Morbi ultricies quam urna, eu cursus ante dignissim in.

event-img
event-img
event-img
medicine-image

Fluocinonide

Date: Thursday, April 28, 2022 /

Fluocinonide is a synthetic glucocorticoid receptor initiated by transcription of the ligand-receptor complex to the nucleus and transcriptional activation of genes containing glucocorticoid responsive elements. Fluocinonide has been used in trials studying the treatment and prevention of Candida Infection, Oral Lichen Planus, Macular Degeneration, and Candida Keratitis/Endophthalmitis. It was patented in 1964 and approved for medical use in 1971.

OUR CLIENTS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque pellentesque auctor massa eu fermentum purus pellentesque eu.

ACCREDITATION

We are committed to excellence in medical research, proudly holding accreditations that ensure the highest standards of quality and ethics in our work. These certifications reflect our dedication to reliable and impactful outcomes.

Etiam a nisl ipsum. Integer vel est odio. Sed condimentum, tortor ac porta vestibulum, mauris metus venenatis diam, tincidunt congue nulla purus in lectus. In finibus dignissim porttitor. Maecenas suscipit libero nibh, ac finibus purus pharetra id. Curabitur eu est pharetra nisi.

SCHEDULE MEETING WITH US